Ischemic heart disease, a narrowing of the arteries supplying blood to the heart, is a leading cause of death throughout the world. A hybrid molecular imaging technique called positron emission tomography and magnetic resonance (PET/MR) imaging, which tells doctors vital information about cardiac and arterial function, has been found to be an effective molecular imaging tool for detecting coronary artery disease (CAD), say researchers at the Society of Nuclear Medicine and Molecular Imaging’s 2014 Annual Meeting (SNMMI).
GE Healthcare Unveils Upgradeable PET/CT System

June 11, 2014 — GE Healthcare introduced its Discovery IQ PET/CT (positron emission tomography/computed tomography) system at the 2014 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in St. Louis. The system enables both high image quality and intelligent quantitation. It is pending 510(k) clearance from the U.S. Food and Drug Administration (FDA) and not available for sale in the United States.

June 11, 2014 — VuCOMP Inc. announced it has received U.S. Food and Drug Administration (FDA) approval for M-Vu CAD for mammography version 3.1. Concurrently, VuCOMP is releasing an update to its CAD (computer-aided detection) station, which includes the ability to process additional standard screening views.

June 11, 2014 — Erasmus University Medical Center (Erasmus MC) in Rotterdam, the Netherlands, announced the purchase of Elekta Versa HD linear accelerators (linacs) and a software upgrade including the Mosaiq oncology information system (OIS) and Monaco 5 treatment planning system.


Many people develop depression in the latest stages of life, but until now doctors had no idea that it could point to a build up of a naturally occurring protein in the brain called beta-amyloid, a hallmark of Alzheimer’s disease. In fact, late-life depression could become a major risk factor for developing Alzheimer’s faster than others, according to research unveiled at the Society of Nuclear Medicine and Molecular Imaging’s 2014 Annual Meeting (SNMMI).
SNMMI Radioluminescence Single Cells Nuclear Imaging

With a new molecular imaging system powerful enough to peer down to 20-micrometer resolution, researchers can now use radioluminescence to examine the characteristics of single, unconnected cells. The result is a fascinating picture of diversity among cells previously assumed to behave the same, revealed researchers at the Society of Nuclear Medicine and Molecular Imaging’s 2014 Annual Meeting (SNMMI).

Taking their pick, biomedical researchers can now conduct five different imaging studies in one scan with a state-of-the-art preclinical molecular imaging system that scientists unveiled during the Society of Nuclear Medicine and Molecular Imaging’s 2014 Annual Meeting.

Advanced cancer of the neuroendocrine system can lead to dismal prognoses, but a novel therapy is packing a punch by uniting powerful radionuclide treatment and chemotherapy drugs, revealed researchers at the Society of Nuclear Medicine and Molecular Imaging’s 2014 Annual Meeting.

Low back pain is not only excruciating but also debilitating for countless sufferers. Unfortunately, not everyone responds to treatment. A molecular imaging scan in addition to a conventional bone scan can provide the necessary information about the physiological health of the spine to select the most appropriate pain-killing treatment protocol, say researchers at the Society of Nuclear Medicine and Molecular Imaging’s 2014 Annual Meeting (SNMMI).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now